Vipivotide tetraxetan
Need Assistance?
  • US & Canada:
    +
  • UK: +

Vipivotide tetraxetan

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Vipivotide tetraxetan is a human prostate-specific membrane antigen (PSMA)-targeting ligand that binds to PSMA-expressing tumor cells. Vipivotide tetraxetan could be labeled with 177Lu for imaging and detecting tumors.

Category
Peptide Inhibitors
Catalog number
BAT-016855
CAS number
1702967-37-0
Molecular Formula
C49H71N9O16
Molecular Weight
1042.14
Vipivotide tetraxetan
IUPAC Name
(2S)-2-[[(1S)-1-carboxy-5-[[(2S)-3-naphthalen-2-yl-2-[[4-[[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]methyl]cyclohexanecarbonyl]amino]propanoyl]amino]pentyl]carbamoylamino]pentanedioic acid
Synonyms
PSMA-617; PSMA 617; PSMA617; Glu-NH-CO-NH-Lys[(2-Nal)-Amc-DOTA]
Appearance
White to off-white solid
Purity
>98.0%
Sequence
Glu-NH-CO-NH-Lys[(2-Nal)-Amc-DOTA]
Storage
Store at -20 °C
Solubility
DMSO: 125 mg/ml (11995 mm, need ultrasonic)
InChI
InChI=1S/C49H71N9O16/c59-40(28-55-17-19-56(29-42(62)63)21-23-58(31-44(66)67)24-22-57(20-18-55)30-43(64)65)51-27-32-8-12-35(13-9-32)45(68)52-39(26-33-10-11-34-5-1-2-6-36(34)25-33)46(69)50-16-4-3-7-37(47(70)71)53-49(74)54-38(48(72)73)14-15-41(60)61/h1-2,5-6,10-11,25,32,35,37-39H,3-4,7-9,12-24,26-31H2,(H,50,69)(H,51,59)(H,52,68)(H,60,61)(H,62,63)(H,64,65)(H,66,67)(H,70,71)(H,72,73)(H2,53,54,74)/t32?,35?,37-,38-,39-/m0/s1
InChI Key
JBHPLHATEXGMQR-VLOIPPKDSA-N
Canonical SMILES
C1CC(CCC1CNC(=O)CN2CCN(CCN(CCN(CC2)CC(=O)O)CC(=O)O)CC(=O)O)C(=O)N[C@@H](CC3=CC4=CC=CC=C4C=C3)C(=O)NCCCC[C@@H](C(=O)O)NC(=O)N[C@@H](CCC(=O)O)C(=O)O
Online Inquiry
Inquiry Basket